CARROLL J MARTIN - Insider Non-Derivative Transactions at Esperion Therapeutics, Inc. (ESPR) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on May 23, 2024, CARROLL J MARTIN's relationship to Esperion Therapeutics, Inc. (ESPR) is Director, and currently has 64,650 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ESPR insiders.

Data Source: SEC.
CARROLL J MARTIN - Insider Non-Derivative Transactions of ESPR Common Stock
CARROLL J MARTIN - Insider Non-Derivative Transactions at ESPR
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
May 24, 2024 Acquisition -- (Common Stock) 23000 0 64650
Jun 16, 2023 Acquisition -- (Common Stock) 5150 0 41650
May 12, 2023 P -- (Common Stock) 23091 1.57 36500
May 11, 2023 P -- (Common Stock) 8409 1.49 13409